FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110249405> ?p ?o ?g. }

• W2110249405 endingPage "776" @default.
• W2110249405 startingPage "773" @default.
• W2110249405 abstract "Adenoid hypertrophy treatment for children is generally planned in accordance with the degree of airway obstruction and related morbidity. If surgical treatment is indicated, the individual risk/benefit analysis of patients should be assessed in terms of anesthetic and postoperative complications. Although there are few alternative treatment options, these may be considered as a nonsurgical approach in less serious cases. Accordingly, studies about intranasal steroid applications under various protocols have been presented. The prospective, randomized, placebo-controlled study. Tertiary referral center. Patients indicated for surgery were randomly divided into two groups. The study group was treated by fluticasone propionate nasal drops (NSD-nasal steroid drops) of 400 μg/day for 8 weeks. The control group was treated by normal saline (NS) in the same way. All the patients were called for follow-up every 4 weeks. At the end of 8 weeks, statistically significant improvement (p < 0.05) was observed in the NSD treated group compared to the NS treated group in terms of nasal airway obstruction, mouth breathing, speech abnormalities, apnea and night cough. At the end of 8 weeks, the average total symptoms score of the NSD treated group dropped from 13.7 to 2.9 while the NS treated group's score changed from 14.8 to 14.6. After 8 weeks of NSD treatment the initial adenoid/choana (A/C) rate had dropped from 87 to 56% and a total decrease of 35.6% was observed. After 8 weeks of NS treatment the A/C rate dropped from 87 to 85% and a total decrease of 2.2% was observed. In this study, the effect of fluticasone propionate nasal drops on adenoid hypertrophy is examined for the first time. This method provides an effective alternative to surgical treatment in children with adenoid hypertrophy. With the protocol applied in this study 76% of the patients were eliminated the surgery and removed from the surgical waiting list." @default.
• W2110249405 created "2016-06-24" @default.
• W2110249405 creator A5052099894 @default.
• W2110249405 creator A5083284569 @default.
• W2110249405 creator A5083879096 @default.
• W2110249405 creator A5084712439 @default.
• W2110249405 creator A5090596079 @default.
• W2110249405 date "2010-07-01" @default.
• W2110249405 modified "2023-10-02" @default.
• W2110249405 title "Medical treatment of adenoid hypertrophy with “fluticasone propionate nasal drops”" @default.
• W2110249405 cites W1568358599 @default.
• W2110249405 cites W1972373901 @default.
• W2110249405 cites W1973166946 @default.
• W2110249405 cites W1975255985 @default.
• W2110249405 cites W1979476552 @default.
• W2110249405 cites W1979933646 @default.
• W2110249405 cites W1986834309 @default.
• W2110249405 cites W1991112544 @default.
• W2110249405 cites W1998647895 @default.
• W2110249405 cites W2015323421 @default.
• W2110249405 cites W2047707249 @default.
• W2110249405 cites W2049984864 @default.
• W2110249405 cites W2066849604 @default.
• W2110249405 cites W2074072665 @default.
• W2110249405 cites W2085264307 @default.
• W2110249405 cites W2090961567 @default.
• W2110249405 cites W2091087005 @default.
• W2110249405 cites W2098343405 @default.
• W2110249405 cites W2110249080 @default.
• W2110249405 cites W2130564126 @default.
• W2110249405 doi "https://doi.org/10.1016/j.ijporl.2010.03.051" @default.
• W2110249405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20430451" @default.
• W2110249405 hasPublicationYear "2010" @default.
• W2110249405 type Work @default.
• W2110249405 sameAs 2110249405 @default.
• W2110249405 citedByCount "42" @default.
• W2110249405 countsByYear W21102494052012 @default.
• W2110249405 countsByYear W21102494052013 @default.
• W2110249405 countsByYear W21102494052014 @default.
• W2110249405 countsByYear W21102494052015 @default.
• W2110249405 countsByYear W21102494052016 @default.
• W2110249405 countsByYear W21102494052017 @default.
• W2110249405 countsByYear W21102494052018 @default.
• W2110249405 countsByYear W21102494052019 @default.
• W2110249405 countsByYear W21102494052020 @default.
• W2110249405 countsByYear W21102494052021 @default.
• W2110249405 countsByYear W21102494052022 @default.
• W2110249405 countsByYear W21102494052023 @default.
• W2110249405 crossrefType "journal-article" @default.
• W2110249405 hasAuthorship W2110249405A5052099894 @default.
• W2110249405 hasAuthorship W2110249405A5083284569 @default.
• W2110249405 hasAuthorship W2110249405A5083879096 @default.
• W2110249405 hasAuthorship W2110249405A5084712439 @default.
• W2110249405 hasAuthorship W2110249405A5090596079 @default.
• W2110249405 hasConcept C105922876 @default.
• W2110249405 hasConcept C141071460 @default.
• W2110249405 hasConcept C142724271 @default.
• W2110249405 hasConcept C203014093 @default.
• W2110249405 hasConcept C204787440 @default.
• W2110249405 hasConcept C27081682 @default.
• W2110249405 hasConcept C2776008533 @default.
• W2110249405 hasConcept C2776804153 @default.
• W2110249405 hasConcept C2777346780 @default.
• W2110249405 hasConcept C2777397205 @default.
• W2110249405 hasConcept C2778333281 @default.
• W2110249405 hasConcept C2779028295 @default.
• W2110249405 hasConcept C2779073326 @default.
• W2110249405 hasConcept C2781163425 @default.
• W2110249405 hasConcept C2781212218 @default.
• W2110249405 hasConcept C42219234 @default.
• W2110249405 hasConcept C71924100 @default.
• W2110249405 hasConcept C85663871 @default.
• W2110249405 hasConceptScore W2110249405C105922876 @default.
• W2110249405 hasConceptScore W2110249405C141071460 @default.
• W2110249405 hasConceptScore W2110249405C142724271 @default.
• W2110249405 hasConceptScore W2110249405C203014093 @default.
• W2110249405 hasConceptScore W2110249405C204787440 @default.
• W2110249405 hasConceptScore W2110249405C27081682 @default.
• W2110249405 hasConceptScore W2110249405C2776008533 @default.
• W2110249405 hasConceptScore W2110249405C2776804153 @default.
• W2110249405 hasConceptScore W2110249405C2777346780 @default.
• W2110249405 hasConceptScore W2110249405C2777397205 @default.
• W2110249405 hasConceptScore W2110249405C2778333281 @default.
• W2110249405 hasConceptScore W2110249405C2779028295 @default.
• W2110249405 hasConceptScore W2110249405C2779073326 @default.
• W2110249405 hasConceptScore W2110249405C2781163425 @default.
• W2110249405 hasConceptScore W2110249405C2781212218 @default.
• W2110249405 hasConceptScore W2110249405C42219234 @default.
• W2110249405 hasConceptScore W2110249405C71924100 @default.
• W2110249405 hasConceptScore W2110249405C85663871 @default.
• W2110249405 hasIssue "7" @default.
• W2110249405 hasLocation W21102494051 @default.
• W2110249405 hasLocation W21102494052 @default.
• W2110249405 hasOpenAccess W2110249405 @default.
• W2110249405 hasPrimaryLocation W21102494051 @default.
• W2110249405 hasRelatedWork W2065080942 @default.
• W2110249405 hasRelatedWork W2110249405 @default.
• W2110249405 hasRelatedWork W2274601244 @default.

• next